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ABSTRACT Solid-state 2H-NMR is routinely used to determine the alignment of membrane-bound peptides. Here we demon-
strate that it can also provide a quantitative measure of the ﬂuctuations around the distinct molecular axes. Using several
dynamic models with increasing complexity, we reanalyzed published 2H-NMR data on two representative a-helical peptides:
1), the amphiphilic antimicrobial peptide PGLa, which permeabilizes membranes by going from a monomeric surface-bound
to a dimeric tilted state and ﬁnally inserting as an oligomeric pore; and 2), the hydrophobic WALP23, which is a typical transmem-
brane segment, although previous analysis had yielded helix tilt angles much smaller than expected from hydrophobic mismatch
and molecular dynamics simulations. Their 2H-NMR data were deconvoluted in terms of the two main helix orientation angles
(representing the time-averaged peptide tilt and azimuthal rotation), as well as the amplitudes of ﬂuctuation about the corre-
sponding molecular axes (providing the dynamic picture). The mobility of PGLa is found to be moderate and to correlate well
with the respective oligomeric states. WALP23 ﬂuctuates more vigorously, now in better agreement with the molecular dynamics
simulations andmismatch predictions. The analysis demonstrates that when 2H-NMR data are ﬁtted to extract peptide orientation
angles, an explicit representation of the peptide rigid-body angular ﬂuctuations should be included.
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The orientation of membrane-bound peptides in lipid bilayers
can be routinely determined by solid-state NMR (SSNMR)
(1,2). For a simple a-helix, this orientation is defined by the
tilt angle of its long axis with respect to themembrane normal,
plus an azimuthal angle giving the rotation of the helix around
its axis. This alignment is typically calculated from a number
of local orientational constraints acquired from 2H- 19F- or
15N-labeled peptides (3–15). However, such analysis of the
NMR data normally ignores, or oversimplifies, the molecular
motions of the peptide, which are clearly nonnegligible in
a fluid lipid bilayer. Other spectroscopic methods for esti-
mating peptide orientation in membranes, such as oriented
circular dichroism (16,17) or attenuated total reflection Four-
ier-transform infrared spectroscopy (18), are not able to
provide this dynamic information either.
As relatively small molecules, peptides are expected to be
highly mobile in liquid crystalline membranes. For instance,
internal peptide-plane librations occur on the timescale of
109 s, whereas whole-body axial diffusion and off-axial
reorientations may take place on the 108–107 s and
106–105 s timescales, respectively (19,20). Because these
molecular motions are much faster than the SSNMR acquisi-
tion timescale of up to a second, peptide dynamics will lead
to a partial averaging of the anisotropic NMR signals. The
amplitudes of fluctuation can thus have a direct effect on
the apparent peptide orientation angles, especially when
these are calculated on the usual assumption of a simple
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0006-3495/09/04/3223/10 $2.00static model. This problem was recently demonstrated by
molecular dynamics (MD) simulations on the model peptides
WLP23, KLP23, and WALP23 (21,22). The authors showed
that large deviations can exist between the actual time-aver-
aged helix tilt and rotation angles as deduced directly from
the MD traces and the calculated values that were either eval-
uated indirectly from the simulated 2H-NMR splittings or
obtained directly by experiment. In fact, these and other
MD studies (23,24) have systematically yielded much larger
tilt angles of the peptides (30–40) than determined from
2H-NMR experiments of the same systems (4–10).
It is therefore essential to account for motional averaging
when calculating the peptide orientation from SSNMR data.
However, so far, peptide mobility has been ignored or, at
most, has been considered by introducing a fixed or adjust-
able order parameter S (3,5,7,8,10–12,14). Here, we present
a detailed analysis of the influence of peptide dynamics on
the interpretation of 2H-NMR data, where the anisotropic
fluctuations of the peptide motions of and around its helix
axis are modeled explicitly. By reanalyzing the published
2H-NMR data from several peptide/lipid systems, using
a number of alternative models of increasing complexity to
account for peptide mobility, we obtain what we believe is
a new view of peptide dynamics in membranes. In an accom-
panying article (25) we do a similar analysis of the influence
of dynamics on the interpretation of 15N-NMR data from
polarization inversion spin exchange at the magic angle
(PISEMA) experiments.
Our systems of choice are the amphipathic antimicrobial
peptide PGLa and the hydrophobic model peptide
WALP23. Each of these has been selectively labeled with
doi: 10.1016/j.bpj.2009.02.040
3224 Strandberg et al.Ala-d3 in at least eight different positions, and
2H quadrupolar
splittings have been systematically collected in different
model membranes and under different conditions (7,10–12).
The selected examples thus represent the various orientations
that are typically encountered for helical peptides in liquid
crystalline membranes, as illustrated in Fig. 1, which should
be of general interest formany other systems too. Specifically,
we consider here the amphiphilic PGLa helix in DMPC,
bound flat to the membrane surface in the so-called ‘‘S-state’’
as a monomer (Fig. 1 A), embedded in the bilayer in a tilted
‘‘T-state’’ as a putative dimer (Fig. 1 B), and immersed in
the membrane in the ‘‘I-state’’ in an almost upright alignment
(Fig. 1 C). Unlike PGLa, the fully hydrophobic WALP23 is
always expected to assume a transmembrane alignment,
e.g., in DMPC (Fig. 1 D), although in a DLPC bilayer, the
mismatch in hydrophobic thickness is expected to induce
a more significant tilting (Fig. 1 E) (3,7,26).
For each of these five cases we have calculated the best-fit
helix tilt and azimuthal rotation angles by an rmsd analysis of
the NMR data, using for these analyses several different
dynamic models. We find that the inclusion of dynamics
improves the quality of the fits, and the applicability versus
complexity of the models is discussed in terms of the
multiple-parameter fits. Obviously, the apparent deviations
of the calculated structures depend primarily on the extent
of motion, but more remarkably, the reliability of the anal-
ysis depends also very much on the actual orientation of
the peptide. Altogether, the most appropriate model, which
assumes explicit fluctuations of and around the helix axis,
appears to be most realistic and allows for the first time, to
our knowledge, to estimate the amplitudes of peptide
whole-body motions in the membrane.
METHODS
Structural model for the conformation
and orientation of membrane peptides
The peptides studied here are known to be a-helical in lipid environments
from circular dichroism and NMR analysis (6,27–30) Hence, they are
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FIGURE 1 Representative orientational states of membrane-bound
peptides in the different peptide-lipid systems studied. (A) Surface-aligned
amphiphilic peptide (S-state), PGLa/DMPC1:200. (B) Tilted dimer (T-state),
PGLa/DMPC 1:50. (C) Membrane-inserted oligomer (I-state) in a putative
pore, PGLa/MAG/DMPC/DMPG 1:1:75:25. (D) Transmembrane state of
a monomeric hydrophobic peptide, WALP23/DMPC 1:100. (E) Mismatched
transmembrane state of a monomeric hydrophobic peptide, WALP23/DLPC
1:100. In all panels the hydrophobicity of peptides and lipids is indicated by
a gray scale, where the more polar parts are shaded darker.
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tion for all residues (6,8). The geometric analysis of labeled alanines
(GALAmethod) utilizes Ala-d3 residues as selective labels (8,11), for which
the orientation of the Ca–CbD3 vector is fixed by the backbone structure.
This molecular geometry is described by a pair of angles, a and b. The first
one is defined within the plane normal to the helix axis through the Ca atom,
and it is the angle formed between the projection of the Ca–Cb bond onto
that plane and a radial vector from the peptide axis to the Ca. In turn, b is
the angle between the Ca–Cb bond and the helix axis. In an a-helical poly-
alanine model constructed using SYBYL (Tripos, St. Louis, MO) with back-
bone angles 4¼ –58 and j¼ –47 and a pitch between contiguous residues
of g ¼ 100, the values of a and b are 53.2 and 121.1, respectively (6).
The definitions of the angles are shown in Fig. S1 in the SupportingMaterial.
The orientation of the peptide helix in the lipid membrane is defined by
the tilt angle t between the helix axis and the membrane normal and by
the azimuthal rotation angle r about the helix axis (Fig. 2). The reference
for the zero value of r can be set according to different conventions.
Here, in all cases, we will use the same convention as in our publications
on PGLa (5,8,10–12,27), for which r ¼ 0 when the radial vector pointing
through Ca of residue number 12 lies in a plane parallel to the membrane
surface. However, whenever a different convention was used in previous
experimental work, as for WALP23 peptides, to avoid confusion, we also
state the r-values according to those original publications (3,7).
Theoretical splittings in static and dynamic
models
Calculations were performed on a PC using FORTRAN programs. The basic
formula connecting the deuterium quadrupolar splittings to the structure and
orientation of a helical peptide is (7)
Dnq ¼ Dn0q 1=2

3cos2bðcost sint cosd tanbÞ21; (1)
where Dnq is the measured quadrupolar splitting, and Dnq
0 is the maximum
splitting that is related to the quadrupolar coupling constant e2qQ/h. The
angles t (the helix tilt) and b are defined above, and d is the local azimuthal
rotation angle of the C-CD3 bond vector of an Ala-d3 residue, which in turn
is related to the helix azimuthal rotation, r, by d ¼ r þ a þ q. Here, q is
the angle around the peptide axis between the reference residue (see definition
above) and the CD3-labeled Ala residue. For a regular helix q ¼ ng, with n
being the number of residues between the reference and the labeled residue,
andg is defined above (7,10). Togetherwithg, the bond anglesa and b define
the rigid helical peptide conformation (see above and Fig. S1).
Equation 1 represents a static model that can be fit to a set of experimental
2H-NMR splittings. To account for motional averaging in the most simplistic
way, this expression can be multiplied by an order parameter 0 % S % 1,
which has the effect of scaling down all couplings (4,5,8,10–12). In
a more advanced model of peptide dynamics, we can also describe the oscil-
latory fluctuations of the peptide around its helix axis by assuming
a Gaussian distribution of r angles, centered at r0, and with a standard
deviation of sr (21);
A B
FIGURE 2 Definition of the helix tilt angle t and its azimuthal rotation r,
illustrated here for PGLa in the S-state (for details see text).
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where N is a normalization constant, N¼ (sr O(2p))1. The splittings calcu-
lated for all different r-angles are weighted by the probability distribution
and integrated to give the averaged effective splitting Dnq. An analogous
calculation can be done to account for a distribution of t-angles, correspond-
ing to a wagging of the helix axis, using a Gaussian distribution centered at
t0 and with a width of st. Ultimately, both t- and r-fluctuations can be
considered simultaneously by using Gaussian distributions of the two angles
and performing a two-dimensional integration.
When analyzing the 2H-NMR data using any of these models, the calcu-
lated quadrupole splittings for each CD3-labeled position are compared with
the experimental value of the splitting, and the root mean-square deviation
(rmsd) is minimized using a multidimensional grid search of the free param-
eters. Because the signs of the experimental splittings are unknown, the
fits and rmsd calculations are performed using the absolute values of the
calculated splittings.
RESULTS AND DISCUSSION
Peptide-lipid systems used in the study
To test and compare the various dynamic models, they are
applied here to several different peptide/lipid systems
covering a wide range of orientations, oligomerization, and
binding modes. Each case chosen has been studied in depth
by solid-state 2H-NMR using peptides labeled with Ala-d3 in
at least eight different positions, which gives sufficiently
large data sets to allow reliable fits with up to five free param-
eters. All the data have been published previously, and for
experimental details, the reader should consult the original
articles (7,10,12). See also comments on the data in the
Supporting Material.
The antimicrobial peptide PGLa (GMASKAGAIAG
KIAKVALKAL-amide) forms an amphipathic a-helix in
lipid environments. For a peptide/lipid molar ratio (P/L) of
1:200, the helix was found to lie almost parallel to the
membrane surface (8,10). This so-called ‘‘S-state’’ (see
Fig. 1 A) is proposed to be the preferred state for most amphi-
pathic peptides at low concentration. At a higher concentra-
tion of PGLa inDMPC (P/L¼1:50), an oblique tilt of the helix
was observed (see Fig. 1 B), and this so-called ‘‘T-state’’ has
been proposed to consist of peptide dimers (8,10). A similar
T-state has been found for other amphipathic peptides and
might be common (14,28). A third orientational state was de-
tected for PGLa in 1:1 mixtures with magainin-2 (MAG),
another antimicrobial peptide found in the same frog skin,
which is known to have a synergistic effect on PGLa (33).
In the PGLa/MAG system, PGLa was found to have a small
tilt angle (12). This transmembrane ‘‘I-state’’ indicates the
existence of a transmembrane pore (see Fig. 1 C). Such
a pore has been suggested to be the physical cause of bacterial
death, and it is biologically relevant to study this state for
antimicrobial peptides in general (17,29,30).
Transmembrane model peptides were first introduced by
Davis (31). As a representative case, we chose here
WALP23 (acetyl-GWW(LA)8LWWA-amide) from the
WALP family of peptides, which has been studied systemat-ically by Killian et al. (for a recent review see Killian and
Nyholm (32)). The orientation of the peptide was determined
with 2H-NMR in different lipid systems to examine the effect
of hydrophobic mismatch (7). We here use data from
WALP23 in DMPC (almost matching, see Fig. 1 D), and in
DLPC (where the peptide is too long and is expected to tilt,
see Fig. 1 E). The calculated tilt angles increased slightly
with decreasing membrane thickness, but they covered only
a small range (5 to 8 for WALP23, from thicker toward
thinner membranes), which appears insufficient to provide
much mismatch relief (7). Moreover, several MD simulations
performed on WALP and related peptides in different lipid
systems have generally shownmuch larger tilt angles (21–23,
27,33–37). It is therefore interesting to understand the
discrepancy between the NMR and MD analysis, which has
been recently attributed to the question of whether and how
peptide dynamics is considered in the NMR analysis (21,22).
Evaluation of alternative models of peptide
orientation and dynamics
Model 1: Static splitting (ﬁt of t and r)
In the simplest approach, the experimental data are fitted to
Eq. 1 with the tilt angle t and the azimuthal rotation r as
the only free parameters. The maximum quadrupolar split-
ting Dnq
0 is reported in the literature with a value of Qcc ¼
168 kHz for a completely immobile aliphatic 2H-C bond,
which corresponds to a maximum splitting for a rotating
CD3-group of Dnq
0 ¼ 84 kHz (38). We use this value in
Model 1 to evaluate the peptide orientation (see below) under
the assumption of completely static conditions.
Model 2: Scaled splitting (ﬁt of t and r)
In dry peptide powders at room temperature, we experimen-
tally obtain a maximum splitting of only ~74 kHz (P. Trem-
ouilhac, E. Strandberg, P. Wadhwani, and A. S. Ulrich,
unpublished results for Ala-d3-labeled PGLa), which is indic-
ative of some intrinsic internal motions of the peptide. Similar
values are also observed for other Ala-d3-labeled peptides. In
Model 2we therefore use this value ofDnq
0¼74 kHz instead of
the static splitting of Model 1, as the membrane-bound
peptides are likely to be at least as mobile as in a dry powder.
This choice is equivalent to introducing a scaling factor (order
parameter) Si ¼ 0.88, accounting for some intrinsic internal
mobility of the peptide that would reduce the maximum value
of the splitting down to the dry-powder value (3,7).
The best-fit values of t and r are listed in Table 1 for the
different peptide-lipid systems, using either Dnq
0 ¼ 84 kHz
(Model 1) orDnq
0¼ 74 kHz (Model 2). Generally, for a given
peptide/lipid system, it is seen that the values of t and r are
almost the same, irrespective of the Dnq
0 value (except for r
in the S-state of PGLa). Yet, Model 2 gives better solutions
with lower rmsd values compared to Model 1. This finding
confirms that the peptides experience some motional aver-
aging, which can be advantageously accounted for by using
Biophysical Journal 96(8) 3223–3232
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Peptide/lipid system
Model 1 Dnq
0 ¼ 84 kHz (Si ¼ 1) Model 2 Dnq0 ¼ 74 kHz (Si ¼ 0.88) Model 3 variable S (0 % S% 1)
t/ r/ rmsd/kHz t/ r/ rmsd /kHz t/ r/ S rmsd /kHz
PGLa in the S-state* 97 34 8.0 97 117 5.7 98 115 0.70 2.1
PGLa in the T-state* 121 113 8.0 124 112 3.9 126 111 0.78 1.2
PGLa in the I-statey 162 97 2.2 158 98 1.2 157 98 0.84 1.1
WALP23 in DMPCz 4 293 (167) 2.2 6 300 (160) 1.5 7 302 (158) 0.72 1.0
WALP23 in DLPCz 3 266 (194) 3.4 7 285 (175) 4.0 15 318 (142) 0.51 2.3
*From Strandberg et al. (10).
yFrom Tremouilhac et al. (12).
zFrom Strandberg et al. (7). The r-values calculated according to the conventions of the original WALP23 publication are given in parentheses to allow
comparison with the previous analysis.a scaled quadrupolar coupling constant, as previously used
(3,7). Nevertheless, the errors are still rather large in some
cases (intrinsic experimental errors are ~1 kHz); hence
even Model 2 with a scaled splitting does not appear to
describe these systems appropriately.
Model 3: Variable S (ﬁt of t, r, and S)
We now consider additional peptide dynamics, other than
that included via the initial Si ¼ 0.88. For clarity, we intro-
duce a second order parameter, Sr, to account for the motions
not captured by Si, such as additional internal vibrations and
especially partial rotations and wobbling of the whole mole-
cule, which are expected to occur in the bilayer environment.
The global order parameter S, which corresponds to the total
dynamic averaging, is a product of the two order parameters
(S ¼ Si  Sr, 0% S% 1) and will be used as a fitting param-
eter together with t and r. The adjustable order parameter S
acts as a scaling factor to reduce the nominal Dnq
0 ¼ 84 kHz
coupling constant. Thus, Models 1 and 2 are special cases of
the more general Model 3. This variable S model has been
introduced and successfully used by our group as a rough
measure of dynamics in the analysis of PGLa and many other
peptides (2,4,8,10–12,14,39).
Table 1 contains the best-fit values of t, r, and S for the
different peptide-lipid systems. The variable S model
produces better fits than the static models used above, with
all rmsd values between 1 kHz and 2 kHz. The biggest
improvements in rmsd within each peptide system are seen
for the small S values, namely for PGLa in the S-state and
for WALP23. The model dependence is not so pronounced
for PGLa in the I-state, which has a high S value and is the
least mobile system. It is also seen that the angles t and r
are similar to those obtained with Model 2 except for
WALP23 in DLPC, which has a particularly small S (and
for which t goes from 7 to 15). The data are often analyzed
by rmsd plots and helical wave plots, as described in the
Supporting Material.
Model 4: Explicit azimuthal ﬂuctuations (ﬁtted t, r0, and sr)
In the next models we still perform a three-parameter fit, but
instead of using a variable order parameter S, we describe the
Biophysical Journal 96(8) 3223–3232peptide dynamics in a more explicit manner. First, let us
consider specific whole-body peptide dynamics, which
consists of rotational oscillations around the helix axis.
These fluctuations can be modeled with a Gaussian (normal)
frequency distribution of the r-angle, which assigns
maximum probability to the mean value r0 and is character-
ized by a certain standard deviation of sr (there is 68% prob-
ability that r is within the interval r0  sr). The choice of
a Gaussian distribution is motivated mainly by our previous
MD simulations (21). A uniform distribution, with equal
probability over a specified range of angles, although easy
to implement, would disagree with the MD results
(21,22,35). On the other hand, more complex distributions,
such as a bimodal distribution centered on two preferred
angles, would introduce additional parameters and be
much too complex to allow finding a solution with the
amount of data usually available. We assume that the fluctu-
ations are fast compared to the NMR timescale, so that the
distribution will lead to an averaging of the quadrupolar
splittings in an anisotropic way, thus modifying the shape
of the helical wave curve. We use the dry powder value
Dnq
0 ¼ 74 kHz from Model 2 as the quadrupolar splitting
constant, assuming that the internal dynamics in the peptide
powder will be present to a similar extent for peptides in
a hydrated membrane (Si ¼ 0.88).
Fits were systematically performed for the peptide/lipid
systems over a range of sr-values. The results are presented
in Fig. 3, where the best-fit values of t, r0, and the correspond-
ing rmsd are shown as a function of the standard deviation sr.
The best-fit values for the different systems are given in
Table 2. The results for PGLa in the S-state are presented in
Fig. 3 A. It is seen that there is a clear minimum in the rmsd
curve at sr ¼ 19. However, for sr in the range of up to 35
the best-fit t and r0 values are almost constant and within
2 of the best values of Model 3 (variable S). We conclude
that rotation about the helix axis with a distribution width
sr of 19
 can give a good fit and that t and r0 are quite well
defined for this surface-bound monomeric peptide. For the
putative PGLa dimers in the T-state, we observe a similar
behavior (Fig. 3 B), with a best fit again for sr ¼ 20, and
corresponding t and r0 very similar compared to those from
Model 3, although with slightly larger rmsd (see Table 2).
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FIGURE 3 Finding the best-fit value for the azimuthal fluctuation sr and visualization of the corresponding variations in t and r0 (Model 4). The dashed line
in each column indicates the best fit. (A) PGLa in the S-state, giving sr¼ 19, r0¼ 117. (B) PGLa in the T-state, giving sr¼ 20, r0¼ 111. (C) PGLa in the
I-state, giving sr in the range of 0–25
, r0 ¼ 97. (D) WALP23 in DMPC, giving sr ¼ 89, r0 ¼ 302. WALP23 in DLPC has a similar appearance as in
DMPC (data not shown).For the oligomeric assembly of PGLa in the transmem-
brane I-state, the situation is quite different (Fig. 3 C). We
see no clear minimum, and for sr in the range of 0
 to 25
the rmsd remains very low, between 1.2 and 1.3 kHz.
However, the tilt angle is here more sensitive to the r-distri-
bution, going from 158 down to 145 with increasing sr
(from 0 to 40), whereas the average azimuthal rotation r0
changes only by a few degrees. It seems in this case that
including averaging motions around the helix axis does notimprove the fits but introduces ambiguity of the tilt because
there are many different combinations of t and sr giving the
same, or very similar, rmsd.
The most striking effect is seen for the transmembrane
WALP peptides. For WALP23 in DMPC (Fig. 3 D), the
best fit is obtained for a very broad distribution of r (sr ¼
89). Clearly, there is a considerable probability for all
azimuthal angles, meaning that the peptide can exhibit virtu-
ally complete rotation about its helix axis, although still withTABLE 2 Best-ﬁt parameters using Gaussian distributions of either r (Model 4) or t (Model 5) or both simultaneously (Model 6), in all
cases with Dnq
0 ¼ 74 kHz (Si ¼ 0.88)
Peptide/lipid system
Model 4 Model 5 Model 6
t/ r0/ sr/ rmsd /kHz t0/ st/ r/ rmsd /kHz t0/ st/ r0/ sr/ rmsd/kHz
PGLa in the S-state* 96 117 19 2.2 100 26 115 2.3 98 17 115 15 2.0
PGLa in the T-state* 122 111 20 1.3 129 16 112 1.4 125 11 111 15 1.2
PGLa in the I-statey 157 97 1-25 1.2 157 8 99 1.1 155 8 98 20 1.1
WALP23 in DMPCz 18 302 (158) 89 0.9 6 8 299 (161) 1.4 14 15 302 (158) 71 0.9
WALP23 in DLPCz 34 317 (143) 91 2.3 8 15 285 (175) 3.6 29 26 317 (143) 66 2.2
*From Strandberg et al. (10).
yFrom Tremouilhac et al. (12).
zFrom Strandberg et al. (7). The r-values calculated according to the conventions of the original WALP23 publication are given in parentheses to allow
comparison with the previous analysis.Biophysical Journal 96(8) 3223–3232
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all sr-values (r0 varies <10
 when sr changes from 0 to
140). However, and most notably, the calculated tilt angle
increases with sr, from 6
 for sr ¼ 0 to 19 at sr ¼ 89.
For WALP in DLPC, a similar behavior is obtained (result
shown in Table 2 but not in Fig. 3).
Fig. S3 visualizes the effect of rotation around the helix
axis on the helical waves, and illustrates why this type of
dynamics has a larger effect on the fit of peptides in a trans-
membrane orientation.
Model 5: Explicit wagging ﬂuctuations (ﬁt of t0, st, and r)
As an alternative to Model 4, we may also consider
a Gaussian distribution of tilt angles for a helix with its
azimuthal rotation fixed. Such a peptide can waggle in the
membrane around a most probable, averaged tilt, t0, accord-
ing to a normal probability distribution of width st. This
motion will also lead to an averaging of splittings and will
modify the helical wave curves in a different way compared
to the r distribution Model 4. Fits were performed for all the
peptide/lipid systems using a range of values of st (with Dnq
0
¼ 74 kHz, see above), and the results are presented in Table
2. For PGLa, almost the same orientation is found as for
Models 3 and 4. For PGLa in the I-state, no clear minimum
was found. For WALP23, very small tilt angles are found,
and the rmsd is larger than that for Models 3 and 4. In this
case, the fit is more similar to that of Model 2. A detailed
analysis of Model 5 is given in the Supporting Material,
where fits are also shown in Fig. S6. The small allowed
st-values for the transmembrane (small tilt) peptides can
be understood from the effect of st on helical curves. This
is shown in Fig. S5.Model 6: Explicit t- and r-ﬂuctuations (ﬁt of t0, st, r0, and sr)
It is instructive now to introduce another free parameter in
the fit, to be able to consider two separate distributions of
both t and r. We will treat their respective contributions indi-
vidually, even though these two types of motion are of
course present simultaneously and may partly compensate
each another. Thus, in Model 6, we assume that the t- and
r-fluctuations are independent, and we use Dnq
0 ¼ 74 kHz
(Si ¼ 0.88) to account for nonspecific internal motions.
A two-dimensional map of (st, sr) pairs taken from the
best fits is shown in Fig. 4 A for the case of PGLa in the
S-state, with color-coded rmsd values. Pairs with similar
rmsd cluster together giving banana-shaped regions, indi-
cating that the effects of st and sr are indeed not completely
independent from each other. The preferred region has
rmsd < 2.5 kHz, and a shallow minimum is found for st
¼ 17, sr ¼ 15. Both of these values are smaller than those
found using individual distributions, and they correspond to
the best-fit case of t0 ¼ 98 and r0 ¼ 115. All these values,
together with other results derived from Model 6, are
summarized in Table 2. We note that t0 and r0 represent the
same orientation as the one found above with the variable S
(Model 3) but with a slightly lower rmsd (2.0 kHz). It is also
worth correlating the (st, sr) plot with a (t0, r0) plot with
pairs of best-fit orientation angles mapped to their correspond-
ing color-coded rmsd (Fig. 4 D). In this case, we see that the
banana-shaped region with rmsd < 2.5 kHz in Fig. 4 A
corresponds to a very small area in the (t0, r0) plot, and
only a small range of the angles map to rmsd < 5 kHz.
An analogous analysis for PGLa in the T-state gives
a similar picture (Fig. 4, B and E), where the preferred regionA B C
D E F
FIGURE 4 Plot of fitting the 2H-
NMR data as a function of (st, sr) for
(A) PGLa in the S-state, (B) PGLa in
the T-state, (C) PGLa in the I-state; and
as a function of (t0, r0) for (D) PGLa
in the S-state; (E) PGLa in the T-state;
and (F) PGLa in the I-state. The rmsd
values for each point in the grid-search
are indicated by a color code, with the
same scale for the (st, sr) and (t0, r0)
plots of the same system.
Biophysical Journal 96(8) 3223–3232
Membrane Peptide Dynamics from 2H-NMR Data 3229(rmsd < 2.0 kHz) is now shaped as an arc, and there is
a minimum for st ¼ 11 and sr ¼ 15 (not far from the
values of the S-state). Such a minimum corresponds to
t0¼ 125 and r0¼ 111, which is also very close to the values
found above for a variable S (Model 3), with the same rmsd.
In the (t0, r0) plot, we see again a well-defined minimum,
with a somewhat larger good-fit area compared to PGLa in
the S-state.
The corresponding (st, sr) plot for PGLa in the I-state
(Fig. 4 C) shows an allowed region that is much larger along
the sr dimension. It is seen from the plot that for st ¼ 0,
a large range of sr-values give similar rmsd values, which
explains why no clear minimum was found for Model 4 in
this case (see Fig. S6 C). The best-fit area has a rather narrow
range of st-values but a wide range of sr from 0
 to 30, with
a tentative minimum at st ¼ 8, sr ¼ 20, which is clearly
different from that of the S- or T-states of PGLa. The angular
values corresponding to this point (t0 ¼ 155 and r0 ¼ 98)
compare well with the best fit from the variable S (Model 3),
with the same rmsd. The (t0, r0) plot (Fig. 4 F) has a unique
minimum close to these values, but the region with an rmsd
< 5.0 kHz is much larger than that for PGLa in the S- or
T-state. This means that the peptide orientation can be less
well defined in the I-state, but it is still possible to pinpoint
its alignment in terms of t0 and r0 within ~5 accuracy.
All PGLa systems have revealed well-defined distributions
of t and r that fit the experimental 2H quadrupolar splittings
very well. In all these cases, the best-fit rmsd is the same or
slightly better compared to the analysis using the variable S
(Model 3), and the tilt and azimuthal angles are virtually iden-
tical to the previously reported values based on that model.
However, the newly introduced model of explicit whole-
body fluctuations provides additional dynamic information
on the respective amplitudes of wagging and azimuthal
fluctuations, assuming ideal Gaussian distributions.
For WALP23 the emerging picture is rather different,
presumably because this peptide is much more mobile than
PGLa (see below). For WALP23 in DMPC, the region of
the (st, sr) plot where rmsd < 2 kHz is much wider, espe-
cially along the sr dimension, as illustrated in Fig. 5 A. There
is a shallow minimum around st¼ 15 and sr¼ 71, but the
uncertainty in the fluctuation parameters is much larger than
those for any of the PGLa cases described above. Clearly, the
uniformly hydrophobic transmembrane peptide undergoes
more extensive azimuthal fluctuations around its helix axis
than the amphiphilic PGLa, although the fluctuations in the
tilt angle are of comparable size. The best-fit orientation is
for t0 ¼ 14 and r0 ¼ 302, and quite a large area in the
(t0, r0) plot corresponds to rmsd < 2.0 kHz (Fig. 5 C). This
solution corresponds to the same azimuthal angle but a
considerably larger helix tilt compared to the analysis above
using the variable Smodel (Model 3 with t¼ 7). The calcu-
lated helix tilt is, in fact, very much larger than the previously
reported angle (3,7). The previous analysis had been based
on a model similar to our Model 2 above (see Table 1).The divergence in t0 is even more pronounced when
WALP23 is embedded in DLPC with shorter acyl chains,
as seen in Fig. 5, B and D (see also Table 2). The best-fit
helix tilt assuming the new dynamic model is t0 ¼ 29,
compared to t ¼ 15 for the variable S (Model 3), or t ¼ 7
(Model 2) or 3, for the static Model 1. Thus, the previously
examined hydrophobic mismatch effect for these types of
WALP peptides, which was found to be unexpectedly small,
has now become much clearer from our dynamic analysis,
which supports more recent interpretations (21,22).
If we assume no intrinsic motion of the peptides (Si ¼ 1),
the explicit dynamic models give, as could be expected,
wider distributions of angles but have almost no effect on
the orientation. Details are given in Table S1 and Table
S2. For a discussion of combining distributions of t and/or
r angles with a variable S, see the Supporting Material.
We thus propose that Model 6 is most appropriate to
extract the best-fit values or at least the feasible ranges of
r0 and t0 from the
2H-NMR data, provided that a sufficient
number of 2H splittings is available, such as the eight values
used here. Additionally, this dynamic analysis can give
a good estimate of the amplitudes of peptide whole-body
motions in the membrane, i.e., the azimuthal fluctuations
A B
C D
FIGURE 5 Plot of fitting the 2H-NMR data as a function of (st, sr) for (A)
WALP23 in DMPC, (B) WALP23 in DLPC; and as a function of (t0, r0)
for (C) WALP23 in DMPC, and (D) WALP23 in DLPC. The rmsd value
for each point in the grid search is indicated by a color code, with the same
scale in all graphs.Biophysical Journal 96(8) 3223–3232
3230 Strandberg et al.represented by sr and the fluctuations of the helix tilt repre-
sented by st. The results for PGLa and WALP23 using
Model 6 are summarized in Table 2, where r0 and t0 describe
the classical alignment of the peptides, and sr and st may be
regarded as describing their dynamic behavior. We see that
the change in tilt angle t0 of PGLa in realigning from the
monomeric S-state to the dimeric T-state and into the oligo-
meric I-state is accompanied by a decrease in the amplitude
of wagging fluctuations. This trend of st going from 17
 to
11 to 8 is in very good agreement with the proposed step-
wise oligomerization of PGLa and the ensuing decrease in
mobility (note that the values of r0 and sr, connected to
the amphiphilic character of the peptide, remain rather unaf-
fected). It is also instructive to compare the mobility of PGLa
in the I-state with that of WALP23 in DLPC, as both trans-
membrane helices have a very similar tilt angle t0 of 25
 (t =
155 and r = 98 is equivalent to t = 25 and r = 278, see
Fig. S2) (PGLa) or 29 (WALP23). Yet, PGLa undergoes
only moderate fluctuations with st ¼ 8 and sr ¼ 20,
whereas WALP23 is vigorously mobile with st ¼ 26 and
sr ¼ 66. These dramatic differences can certainly be attrib-
uted to the respective oligomeric and monomeric states of
these two peptides. Finally, the effect of bilayer mismatch is
nicely illustrated by the comparison of WALP23 in DMPC
and DLPC. The helix is more upright in DMPC (t0 ¼ 14)
compared to the thinner DLPC bilayer (t0 ¼ 29).
Choice of model for the 2H-NMR data analysis
As seen above for the examples of PGLa and WALP23,
using different dynamic models can give distinctly different
results for the calculated peptide alignment. These values are
summarized in Table 3, allowing us to compare the trends in
t0, r0, and rmsd for Models 1 to 6. It is seen that the r0 valuesare hardly affected by whichever model is used (except for
WALP23 in DLPC), so one does not need to worry about
these. The rmsd values are seen to decrease significantly
on introduction of, first, the fixed scaling factor Si ¼ 0.88
(Model 2) and then the variable order parameter (Model
3). Application of the fluctuation model around a single
peptide axis (Model 4 shown here has better rmsd than
Model 5) gives slightly worse rmsd values compared to
Model 3, although the same number of free parameters are
being fitted. Therefore, we conclude that Model 3 with a vari-
able S should be generally preferable to Model 4 in cases
where only a limited number of 2H-NMR data are available
(i.e., when Model 6 cannot be applied).
Attention must be paid to the tilt angle t, as this value is
found to depend most critically on the type of dynamic
model applied. In the case of PGLa, which exhibits only
moderate mobility in any of its three alignment states, the
model dependence is not so pronounced. However, in the
case of the vigorously mobile WALP23, the observed
increase of t on introduction of better dynamic models
suggests that the helix tilt angle gets systematically underes-
timated when dynamics is not taken into account properly
(21,22). The deviations can be up to one order of magnitude
when the completely inappropriate static Model 1 is used
(giving t of 3 for WALP23 in DLPC, as opposed to 29
using Model 6), and they are still a factor of 2 when the
reasonable Model 3 with a variable S is applied (giving t
of 15 for WALP23 in DLPC as opposed to 29, or 7 as
opposed to 14 in DMPC).
Apart from dynamics, the assumed conformational model
also has an influence on the analysis. Using a canonical
a-helix in our previous 19F- and 2H-NMR studies of amphi-
pathic membrane-bound peptides has resulted in good fits to
the data (4,5,8,10–12,14). The hydrophobic transmembraneTABLE 3 Comparison of dynamic models
Dynamic model
Peptide system Model 1 (S ¼ 1) Model 2 (S ¼ 0.88) Model 3 (0 % S% 1) Model 4 (Variable r) Model 6 (Variable t, r)
Tilt t ()* 97 97 98 96 98
PGLa in the S-state Rotation r ()* 34 117 115 117 115
Rmsd (kHz) 8.0 5.7 2.1 2.2 2.0
Tilt t ()* 121 124 126 122 125
PGLa in the T-state Rotation r ()* 113 112 111 111 111
Rmsd (kHz) 8.0 3.9 1.2 1.3 1.2
Tilt t ()* 162 158 157 157 155
PGLa in the I-state Rotation r ()* 97 98 98 98 98
Rmsd (kHz) 2.2 1.2 1.1 1.2 1.1
Tilt t ()* 4 6 7 18 14
WALP23 in DMPC Rotation r ()* 293 300 302 302 302
Rmsd (kHz) 2.2 1.5 1.0 0.9 0.9
Tilt t ()* 3 7 15 34 29
WALP23 in DLPC Rotation r ()* 266 285 318 317 317
Rmsd (kHz) 3.4 4.0 2.3 2.3 2.2
*For cases of variable tilt and rotation angles, the given values correspond to means of Gaussian distributions.
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PISEMA studies (40–42). Especially for the latter ones, the
implicit assumption of a straight a-helix is expected to be
valid, i.e., in the center of the hydrophobic core where all
the Ala-d3 labels are placed in the case of WALP23.
Nevertheless, it is useful to consider the possible impact of
conformational deviations from this simplified input struc-
ture. One approach is to examine the rmsd values that remain
in the best fits of the different systems studied. For example,
PGLa in the S-state and WALP23 in DLPC show systemat-
ically worse rmsd values for all of the tested models, Models
1–6 (irrespective of any dynamics considered). This observa-
tion suggests that these relatively large residual errors may
be at least in part caused by the actual conformation of the
peptides.
CONCLUSIONS
We have investigated the influence of peptide mobility on
the determination of molecular alignment from 2H-NMR
data, by evaluating different dynamic models of increasing
complexity. For two representative peptides PGLa and
WALP23 in various alignment states, this comprehensive
analysis shows that good fits cannot be obtained unless
some degree of dynamic averaging is included in the model.
The explicit dynamic analysis in terms of t- and r-fluctu-
ations (Model 6) shows that the amphipathic peptide PGLa
undergoes moderate dynamics in liquid crystalline DMPC
membranes. In contrast, the hydrophobic transmembrane
peptide WALP23 undergoes vigorous fluctuations, and
here our data analysis clearly shows that dynamics must
not be ignored; otherwise, the calculated helix tilt angles
are underestimated.
In previous 2H-NMR studies of WALP23 and related
peptides, the helix tilt in different lipid systems had been
found to be very small and only weakly dependent on hydro-
phobic mismatch (3,7,9,13). These reports were not sup-
ported by the results from more recent MD simulations,
which systematically showed larger peptide tilts that were
also much more influenced by bilayer mismatch (21,22).
Our dynamic analysis also yields a larger tilt for WALP23
in DMPC and DLPC than previously published, although
the tilts from the simulations are still larger than these new
experimental values (21–23). On the other hand, the
observed difference between the two lipid systems appears
now in better agreement with the hydrophobic mismatch
predictions. To obtain yet another independent picture for
this kind of mobile transmembrane peptide, an alternative
method such as two-dimensional NMR PISEMA should be
applied, as it has been suggested that rigid-body peptide
dynamics would have only a small influence on the analysis
of polar index slant angles (PISA) wheels in 15N PISEMA
spectra (43). A use of both 2H-NMR on Ala-d3 labels and
15N PISEMA spectra has been reported recently to study
the model membrane peptide GWALP23, which is similarto WALP23, and basically the same tilt has been obtained
from the two methods using static models to analyze the
data (15). However, this might be a particular case with
low peptide mobility. In the accompanying article we have
investigated the effects of dynamics in PISEMA spectra
for a wide range of cases (25), with the conclusion that the
PISEMA analysis of a highly mobile transmembrane peptide
is indeed less model dependent, yet it can yield the same
valuable insights on helix wagging and rotational oscilla-
tions as 2H-NMR.
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